Glenn Steele Jr. M.D. Ph.D., Director at PTC THERAPEUTICS, INC. (PTCT), sold 12,000 shares at $76.35 ($916K) on 2026-01-02, disclosed to the SEC on 2026-01-06.
Open-market sale of $916k PTCT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |